Severe acne can be horrifically debilitating. It leaves sufferers drained of confidence, sometimes even unwilling to leave the house. Case numbers have been growing globally for the past three decades ...
Acne scars may feel like a tough skincare problem to solve, but there are solid treatment options available The post How to ...
Please provide your email address to receive an email when new articles are posted on . IDP-126 — a combination of clindamycin, adapalene and benzoyl peroxide — reduced acne severity in about half of ...
Please provide your email address to receive an email when new articles are posted on . A combination of microencapsulated benzoyl peroxide and microencapsulated tretinoin significantly improved ...
In this digital age of flawless, perfect, poreless skin, dealing with adult acne can be incredibly isolating. Two skinfluencers and a photographer open up about their acne journeys, the pressure for ...
Isotretinoin, commonly referred to as Accutane, is the only approved medical treatment capable of inducing long-term remission of severe acne. Although highly effective, some individuals experience ...
Although many topical or systemic antibiotics exist to treat acne vulgaris, the common inflammatory skin disease is not fully treatable. A new article published in The Journal of Clinical and ...
Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...
Acne vulgaris Researchers examined the relationship between dairy and acne severity and frequency. A significantly lower frequency of acne, as well as lower rates of severe acne, has been reported ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
SAN MATEO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...